Financial reports
10-K
2023 FY
Annual report
13 Mar 24
10-Q
2023 Q3
Quarterly report
7 Nov 23
10-Q
2023 Q2
Quarterly report
10 Aug 23
10-Q
2023 Q1
Quarterly report
8 May 23
ARS
2022 FY
Annual report to shareholders
28 Apr 23
10-K
2022 FY
Annual report
20 Mar 23
10-Q
2022 Q3
Quarterly report
8 Nov 22
10-Q
2022 Q2
Quarterly report
11 Aug 22
10-Q
2022 Q1
Quarterly report
12 May 22
10-K
2021 FY
Annual report
17 Mar 22
Current reports
8-K
Update on Favorable Legal and Regulatory Outcomes Clearing Path for Potential FDA approval of YUTREPIA™ (treprostinil) inhalation powder
1 Apr 24
8-K
Liquidia Corporation Reports Full Year 2023 Financial Results and Provides Corporate Update
13 Mar 24
8-K
Liquidia Corporation Provides Update on New Drug Application for YUTREPIA™ (treprostinil) inhalation powder
25 Jan 24
8-K
Other Events
23 Jan 24
8-K
Liquidia Corporation Announces Updates to Operations Leadership
19 Jan 24
8-K
Liquidia Provides Update on Clinical Pipeline Targeting PAH and PH-ILD
8 Jan 24
8-K
Liquidia Corporation Announces $100 Million in New Financings
4 Jan 24
8-K
Other Events
20 Dec 23
8-K
Unregistered Sales of Equity Securities
14 Dec 23
8-K
Liquidia Announces Pricing of Public Offering of Common Stock
12 Dec 23
Registration and prospectus
S-8
Registration of securities for employees
13 Mar 24
S-8
Registration of securities for employees
13 Mar 24
S-3/A
Shelf registration (amended)
28 Dec 23
S-3
Shelf registration
22 Dec 23
424B2
Prospectus for primary offering
12 Dec 23
S-8
Registration of securities for employees
20 Mar 23
S-8
Registration of securities for employees
20 Mar 23
424B2
Prospectus for primary offering
14 Apr 22
424B5
Prospectus supplement for primary offering
12 Apr 22
S-8
Registration of securities for employees
17 Mar 22
Proxies
PRE 14A
Preliminary proxy
12 Apr 24
DEFA14A
Additional proxy soliciting materials
28 Apr 23
DEF 14A
Definitive proxy
28 Apr 23
PRE 14A
Preliminary proxy
17 Apr 23
DEFA14A
Additional proxy soliciting materials
29 Apr 22
DEF 14A
Definitive proxy
29 Apr 22
DEFA14A
Additional proxy soliciting materials
30 Apr 21
DEF 14A
Definitive proxy
30 Apr 21
Other
EFFECT
Notice of effectiveness
4 Jan 24
CORRESP
Correspondence with SEC
29 Dec 23
UPLOAD
Letter from SEC
28 Dec 23
EFFECT
Notice of effectiveness
15 Sep 21
CORRESP
Correspondence with SEC
10 Sep 21
UPLOAD
Letter from SEC
10 Sep 21
EFFECT
Notice of effectiveness
28 Dec 20
CORRESP
Correspondence with SEC
22 Dec 20
UPLOAD
Letter from SEC
21 Dec 20
EFFECT
Notice of effectiveness
17 Sep 20